Synergistic effect of indomethacin and adriamycin and cisplatin on tumor growth

Kenji Hattori, Ryo Matsushita, Kazuko Kimura, Yoshihiro Abe, Emi Nakashima

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

In this study, we have examined the antitumor effect of combined administrations of indomethacin (IND) with chemotherapeutic drugs on tumor growth. Colon 26 clone 20 (C20) cells and monocyte chemotactant protein-1 (MCP-1) transfected C20 cells (C20βA-2-1) were used and these cells were inoculated into the footpad of BALB/c mice. At day 1 after tumor inoculation, treatment with 0.001% IND via the drinking water was commenced. At days 4, 6, and 8, adriamycin or cisplatin was administered intravenously at a dose of 5 mg/kg or intraperitoneally at a dose of 2 mg/kg, respectively. Although IND, adriamycin and cisplatin only partially reduced the growth of the C20 tumors after treatment with each drug on its own, a marked synergistic effect was observed when they were given in combination. A synergistic effect between IND and cisplatin on C20βA-2-1 was also observed. However, IND itself showed no suppression of C20βA-2-1 tumor growth. These results suggest that combination of indomethacin with chemotherapeutic drugs could be an effective form of cancer chemotherapy. The observed effects may be dependent on the expression of MCP-1.

Original languageEnglish
Pages (from-to)1214-1217
Number of pages4
JournalBiological and Pharmaceutical Bulletin
Volume24
Issue number10
DOIs
Publication statusPublished - 2001

Fingerprint

Indomethacin
Doxorubicin
Cisplatin
Growth
Neoplasms
Clone Cells
Monocytes
Pharmaceutical Preparations
Drinking Water
Colon
Proteins
Drug Therapy
Therapeutics

Keywords

  • Adriamycin
  • Chemotherapy
  • Cisplatin
  • Colon 26
  • Indomethacin

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Synergistic effect of indomethacin and adriamycin and cisplatin on tumor growth. / Hattori, Kenji; Matsushita, Ryo; Kimura, Kazuko; Abe, Yoshihiro; Nakashima, Emi.

In: Biological and Pharmaceutical Bulletin, Vol. 24, No. 10, 2001, p. 1214-1217.

Research output: Contribution to journalArticle

Hattori, K, Matsushita, R, Kimura, K, Abe, Y & Nakashima, E 2001, 'Synergistic effect of indomethacin and adriamycin and cisplatin on tumor growth', Biological and Pharmaceutical Bulletin, vol. 24, no. 10, pp. 1214-1217. https://doi.org/10.1248/bpb.24.1214
Hattori, Kenji ; Matsushita, Ryo ; Kimura, Kazuko ; Abe, Yoshihiro ; Nakashima, Emi. / Synergistic effect of indomethacin and adriamycin and cisplatin on tumor growth. In: Biological and Pharmaceutical Bulletin. 2001 ; Vol. 24, No. 10. pp. 1214-1217.
@article{0cab7d6f98084a9290b05e9e6a761a8e,
title = "Synergistic effect of indomethacin and adriamycin and cisplatin on tumor growth",
abstract = "In this study, we have examined the antitumor effect of combined administrations of indomethacin (IND) with chemotherapeutic drugs on tumor growth. Colon 26 clone 20 (C20) cells and monocyte chemotactant protein-1 (MCP-1) transfected C20 cells (C20βA-2-1) were used and these cells were inoculated into the footpad of BALB/c mice. At day 1 after tumor inoculation, treatment with 0.001{\%} IND via the drinking water was commenced. At days 4, 6, and 8, adriamycin or cisplatin was administered intravenously at a dose of 5 mg/kg or intraperitoneally at a dose of 2 mg/kg, respectively. Although IND, adriamycin and cisplatin only partially reduced the growth of the C20 tumors after treatment with each drug on its own, a marked synergistic effect was observed when they were given in combination. A synergistic effect between IND and cisplatin on C20βA-2-1 was also observed. However, IND itself showed no suppression of C20βA-2-1 tumor growth. These results suggest that combination of indomethacin with chemotherapeutic drugs could be an effective form of cancer chemotherapy. The observed effects may be dependent on the expression of MCP-1.",
keywords = "Adriamycin, Chemotherapy, Cisplatin, Colon 26, Indomethacin",
author = "Kenji Hattori and Ryo Matsushita and Kazuko Kimura and Yoshihiro Abe and Emi Nakashima",
year = "2001",
doi = "10.1248/bpb.24.1214",
language = "English",
volume = "24",
pages = "1214--1217",
journal = "Biological and Pharmaceutical Bulletin",
issn = "0918-6158",
publisher = "Pharmaceutical Society of Japan",
number = "10",

}

TY - JOUR

T1 - Synergistic effect of indomethacin and adriamycin and cisplatin on tumor growth

AU - Hattori, Kenji

AU - Matsushita, Ryo

AU - Kimura, Kazuko

AU - Abe, Yoshihiro

AU - Nakashima, Emi

PY - 2001

Y1 - 2001

N2 - In this study, we have examined the antitumor effect of combined administrations of indomethacin (IND) with chemotherapeutic drugs on tumor growth. Colon 26 clone 20 (C20) cells and monocyte chemotactant protein-1 (MCP-1) transfected C20 cells (C20βA-2-1) were used and these cells were inoculated into the footpad of BALB/c mice. At day 1 after tumor inoculation, treatment with 0.001% IND via the drinking water was commenced. At days 4, 6, and 8, adriamycin or cisplatin was administered intravenously at a dose of 5 mg/kg or intraperitoneally at a dose of 2 mg/kg, respectively. Although IND, adriamycin and cisplatin only partially reduced the growth of the C20 tumors after treatment with each drug on its own, a marked synergistic effect was observed when they were given in combination. A synergistic effect between IND and cisplatin on C20βA-2-1 was also observed. However, IND itself showed no suppression of C20βA-2-1 tumor growth. These results suggest that combination of indomethacin with chemotherapeutic drugs could be an effective form of cancer chemotherapy. The observed effects may be dependent on the expression of MCP-1.

AB - In this study, we have examined the antitumor effect of combined administrations of indomethacin (IND) with chemotherapeutic drugs on tumor growth. Colon 26 clone 20 (C20) cells and monocyte chemotactant protein-1 (MCP-1) transfected C20 cells (C20βA-2-1) were used and these cells were inoculated into the footpad of BALB/c mice. At day 1 after tumor inoculation, treatment with 0.001% IND via the drinking water was commenced. At days 4, 6, and 8, adriamycin or cisplatin was administered intravenously at a dose of 5 mg/kg or intraperitoneally at a dose of 2 mg/kg, respectively. Although IND, adriamycin and cisplatin only partially reduced the growth of the C20 tumors after treatment with each drug on its own, a marked synergistic effect was observed when they were given in combination. A synergistic effect between IND and cisplatin on C20βA-2-1 was also observed. However, IND itself showed no suppression of C20βA-2-1 tumor growth. These results suggest that combination of indomethacin with chemotherapeutic drugs could be an effective form of cancer chemotherapy. The observed effects may be dependent on the expression of MCP-1.

KW - Adriamycin

KW - Chemotherapy

KW - Cisplatin

KW - Colon 26

KW - Indomethacin

UR - http://www.scopus.com/inward/record.url?scp=0035158393&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035158393&partnerID=8YFLogxK

U2 - 10.1248/bpb.24.1214

DO - 10.1248/bpb.24.1214

M3 - Article

VL - 24

SP - 1214

EP - 1217

JO - Biological and Pharmaceutical Bulletin

JF - Biological and Pharmaceutical Bulletin

SN - 0918-6158

IS - 10

ER -